Novo Nordisk rebrands to ‘Novo’ under CEO Mike Doustdar
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
Gifts from pharma companies keep on giving, a new study finds
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Meet Ottava, J&J’s surgical robot leading the healthcare giant into a lucrative new market
Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…
Asthma Antiviral Nasal Spray Secures Funding for Clinical Trial
A new study will evaluate whether a weekly dry powder nasal spray can boost natural defenses and prevent…
Japan to exempt extra charges on OTC-like drugs from tax
The health ministry plans not to impose consumption tax on additional out-of-pocket costs for prescription drugs with ingredients…
New tool predicts heart failure treatment effects on blood pressure, kidney function and serum potassium
A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to effective…
Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
Multi-ancestry genetic score improves risk prediction for Alzheimer’s disease
Late-onset Alzheimer disease (AD) is a progressive disorder characterized by cognitive decline and memory impairment, affecting an estimated…
How AI is changing the pharmaceuticals landscape
Nintedanib, a widely used drug for pulmonary fibrosis, received official approval in 2014 after its development began in…
Lil Nas X’s bipolar diagnosis and mental health treatment| STAT
When Lil Nas X recently disclosed that he had been diagnosed with bipolar disorder, one part of his…
Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
Novo Nordisk CEO defends lawsuit against Eli Lilly: ‘Competition has to be fair’
Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…